Literature DB >> 27610469

Abrogation of MUC5AC Expression Contributes to the Apoptosis and Cell Cycle Arrest of Colon Cancer Cells.

Xijia Zhu1, Xiangkai Long1, Xishun Luo1, Zhike Song1, Shengguo Li1, Haipeng Wang1.   

Abstract

Deregulated expressions of mucins have been found in various malignancies and play a pivotal role in carcinogenesis. MUC5AC, as a secreted mucin, is reported to be aberrantly expressed during epithelial cancer progression, including colon cancer. However, the mechanisms of the oncoprotein MUC5AC in the initiation of colon cancer requires further investigation. Here, we collected colon cancer tissues (n = 20) and corresponding paracancerous tissues (n = 20) and found that the expression of MUC5AC was significantly elevated in colon cancer tissues when compared with the corresponding paracancerous tissues. Immunofluorescence indicated that all colon cancer cell lines, including HT29, SW620, and the normal human intestinal epithelial cells FHC, showed the positive expression of MUC5AC, and SW620 exhibited the highest expression. Moreover, knockdown of MUC5AC in SW620 cells remarkably suppressed cell vitality and promoted apoptosis and G1 cell cycle arrest, resulting in the impaired ability of colony formation. Furthermore, the inhibition of MUC5AC in SW620 cells dramatically repressed the cell migration and invasion. These results demonstrated that MUC5AC as an oncogene could be a promising target in the treatment of colon cancer.

Entities:  

Keywords:  MUC5AC; apoptosis; cell proliferation; colon cancer; metastasis

Mesh:

Substances:

Year:  2016        PMID: 27610469     DOI: 10.1089/cbr.2016.2054

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  4 in total

1.  Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma.

Authors:  Sebastian Dwertmann Rico; Franziska Büscheck; David Dum; Andreas M Luebke; Martina Kluth; Claudia Hube-Magg; Andrea Hinsch; Doris Höflmayer; Daniel Perez; Jakob R Izbicki; Michael Neipp; Hamid Mofid; Thies Daniels; Christoph Isbert; Christoph Fraune; Katharina Möller; Anne Menz; Christian Bernreuther; Patrick Lebok; Till Clauditz; Guido Sauter; Ria Uhlig; Waldemar Wilczak; Ronald Simon; Stefan Steurer; Eike Burandt; Andreas Marx; Till Krech
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

Review 2.  Ramifications of secreted mucin MUC5AC in malignant journey: a holistic view.

Authors:  Shiv Ram Krishn; Koelina Ganguly; Sukhwinder Kaur; Surinder K Batra
Journal:  Carcinogenesis       Date:  2018-05-03       Impact factor: 4.944

3.  Elevated MUC5AC expression is associated with mismatch repair deficiency and proximal tumor location but not with cancer progression in colon cancer.

Authors:  Sebastian Dwertmann Rico; Doris Höflmayer; Franziska Büscheck; David Dum; Andreas M Luebke; Martina Kluth; Claudia Hube-Magg; Andrea Hinsch; Christina Möller-Koop; Daniel Perez; Jakob R Izbicki; Michael Neipp; Hamid Mofid; Hannes Lárusson; Thies Daniels; Christoph Isbert; Stephan Coerper; Daniel Ditterich; Holger Rupprecht; Albert Goetz; Christoph Fraune; Katharina Möller; Anne Menz; Christian Bernreuther; Till S Clauditz; Guido Sauter; Ria Uhlig; Waldemar Wilczak; Ronald Simon; Stefan Steurer; Patrick Lebok; Eike Burandt; Till Krech; Andreas H Marx
Journal:  Med Mol Morphol       Date:  2020-12-29       Impact factor: 2.309

4.  MUC1 and MUC5AC implication in Tunisian colorectal cancer patients

Authors:  Meriam Hazgui; Marwa Weslati; Rahma Boughriba; Donia Ounissi; Dhouha Bacha; Saadia Bouraoui
Journal:  Turk J Med Sci       Date:  2021-02-26       Impact factor: 0.973

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.